Annual ROE
-50.66%
+5.98%+10.56%
December 31, 2023
Summary
- As of February 8, 2025, INZY annual return on equity is -50.66%, with the most recent change of +5.98% (+10.56%) on December 31, 2023.
- During the last 3 years, INZY annual ROE has fallen by -14.97% (-41.94%).
- INZY annual ROE is now -185.31% below its all-time high of 59.38%, reached on December 31, 2019.
Performance
INZY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-88.42%
-19.49%-28.28%
September 30, 2024
Summary
- As of February 8, 2025, INZY quarterly return on equity is -88.42%, with the most recent change of -19.49% (-28.28%) on September 30, 2024.
- Over the past year, INZY quarterly ROE has dropped by -19.49% (-28.28%).
- INZY quarterly ROE is now -113.16% below its all-time high of 671.74%, reached on June 30, 2020.
Performance
INZY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
INZY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.6% | -28.3% |
| 3 y3 years | -41.9% | -63.7% |
| 5 y5 years | -200.9% | -63.7% |
INZY ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.6% | -103.9% | at low |
| 5 y | 5-year | -185.3% | +10.6% | -113.2% | +33.7% |
| alltime | all time | -185.3% | +10.6% | -113.2% | +33.7% |
Inozyme Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -88.42%(+28.3%) |
| Jun 2024 | - | -68.93%(+17.3%) |
| Mar 2024 | - | -58.74%(+5.2%) |
| Dec 2023 | -50.66%(-10.6%) | -55.86%(-0.1%) |
| Sep 2023 | - | -55.93%(-4.8%) |
| Jun 2023 | - | -58.78%(+10.0%) |
| Mar 2023 | - | -53.46%(-1.0%) |
| Dec 2022 | -56.64% | -54.02%(-2.1%) |
| Sep 2022 | - | -55.20%(+1.3%) |
| Jun 2022 | - | -54.47%(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -53.41%(+23.2%) |
| Dec 2021 | -51.82%(+45.2%) | -43.36%(+26.4%) |
| Sep 2021 | - | -34.30%(-16.3%) |
| Jun 2021 | - | -40.97%(-27.2%) |
| Mar 2021 | - | -56.24%(-13.6%) |
| Dec 2020 | -35.69%(-160.1%) | -65.07%(-51.2%) |
| Sep 2020 | - | -133.37%(-119.9%) |
| Jun 2020 | - | 671.74%(-661.7%) |
| Mar 2020 | - | -119.60%(-301.4%) |
| Dec 2019 | 59.38%(+18.3%) | 59.37% |
| Dec 2018 | 50.19% | - |
FAQ
- What is Inozyme Pharma annual return on equity?
- What is the all time high annual ROE for Inozyme Pharma?
- What is Inozyme Pharma annual ROE year-on-year change?
- What is Inozyme Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Inozyme Pharma?
- What is Inozyme Pharma quarterly ROE year-on-year change?
What is Inozyme Pharma annual return on equity?
The current annual ROE of INZY is -50.66%
What is the all time high annual ROE for Inozyme Pharma?
Inozyme Pharma all-time high annual return on equity is 59.38%
What is Inozyme Pharma annual ROE year-on-year change?
Over the past year, INZY annual return on equity has changed by +5.98% (+10.56%)
What is Inozyme Pharma quarterly return on equity?
The current quarterly ROE of INZY is -88.42%
What is the all time high quarterly ROE for Inozyme Pharma?
Inozyme Pharma all-time high quarterly return on equity is 671.74%
What is Inozyme Pharma quarterly ROE year-on-year change?
Over the past year, INZY quarterly return on equity has changed by -19.49% (-28.28%)